Ryan Lake - Jun 5, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Signature
/s/ Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Jun 5, 2021
Transactions value $
-$1,654
Form type
4
Date filed
6/8/2021, 05:04 PM
Next filing
Jul 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Options Exercise +2.5K +0.66% 379K Jun 5, 2021 Direct F1
transaction SCTL Common Stock Tax liability -$1.65K -719 -0.19% $2.30 378K Jun 7, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCTL Restricted Stock Units Options Exercise $0 -2.5K -100% $0.00* 0 Jun 5, 2021 Common Stock 2.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3 On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.